Journals / Turkish Neurosurgery / 2011 / Cilt: 21 - Sayı: 1

Bağışıklık sistemi normal olan olgularda primer santral sinir sistemi lenfoması: Literatür incelemesi ve keşmir deneyimi

Primary cns lymphoma in immunocompetent: A review of literature and our experience from kashmir

Pages
39–47
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Relapse is common after treatment and the overall prognosis is unfavorable.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIm: To study the clinicopathological aspects of primary CNS lymphoma in immunocompetent patients.
📊
Key Findings & Data:Our patients were relatively young with a mean age of 48 years and an age range of 35-60 years.
💡
Conclusion & Impact:Relapse is common after treatment and the overall prognosis is unfavorable.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AIm: To study the clinicopathological aspects of primary CNS lymphoma in immunocompetent patients. Ma terIal and Methods: Sixteen patients with primary CNS lymphoma were analyzed for their clinico-pathological characteristics and followed-up for the treatment and subsequent management in Neurosurgery, and Medical and Radiation Oncology. Results: The fronto-parietal region was the commonest location of CNS lymphoma; four cases of cerebellar lymphoma were seen. Our patients were relatively young with a mean age of 48 years and an age range of 35-60 years. Females outnumbered males with a ratio of 2.7:1. The commonest presentation was focal neurological-deficits and features of raised intracranial pressure. All the patients histologically had diffuse large B-cell lymphoma. Radiologically, most presented as disc-enhancing lesions. Two patients had multiple lesions. Most of the patients (10) died within a mean of 4.4 months (range 2 weeks-16 months). ConclusIon: Primary CNS lymphoma is seen in immunocompetent patients as well. Relapse is common after treatment and the overall prognosis is unfavorable.

Özet

AMAÇ: Bağışıklık sisteminde baskılanma olmayan primer santral sinir sistemi lenfomalı hastaların klinikopatolojik özellikleri. YÖNTEM ve GEREÇ: Primer santral sinir sistemi lenfoması olan 16 hastanın klinikopatolojik özellikleri incelendi ve hastalar beyin cerrahisi, medikal onkoloji ve radyasyon onkolojisi bölümlerinde tedavi ve takip edildi. BULGULAR: Bu seride lenfomanın sıklıkla frontoparietal bölgeye yerleştiği görüldü. Dört vakaya serebellar lenfoma tanısı konuldu. Bizim hastalarımız görece olarak genç yaştaydılar, ortalama yaş 48, yaş aralığı 35-60. Kadın hastalar çoğunluktaydı, kadın/erkek oranı 2.7/1 olara belirlendi. En sık görülen belirti fokal nörolojik defisit ve kafa içi basınç artışına bağlı bulgulardı. Tüm hastaların histolojik tanısı yaygın geniş B hücreli lenfomaydı. MRG’de en sık karşılaşılan lezyon şekli oval görünümlü kontrast tutulumu olan lezyonlardı, iki hastada ise çoklu lezyonlar vardı. SONUÇ: Primer santral sinir sistemi lenfoması bağışıklık sisteminde baskılanma olmayan insanlarda da görülmektedir. Hastalık tedaviye rağmen tekrarlamakta ve hastalığın genel prognozu kötü olarak seyretmektedir.

🔖

Cite This Article

MAKHDOOMI, R., NAYIL, K., RAYEES, A., KIRMANI, A., RAMZAN, A., KHALIL, M. B., DHAR, A., BESINA, S., CHANDA, N., LONE, A. R., QADLRL, S., MAQBOOL, M. (2011). Bağışıklık sistemi normal olan olgularda primer santral sinir sistemi lenfoması: Literatür incelemesi ve keşmir deneyimi. Turkish Neurosurgery, Cilt: 21 - Sayı: 1, 39–47. https://ajindex.com/articles/405098

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Amin–Hanjani S, Griffith RH IV: Cerebral lymphoma
  2. in Youmans Neurological Surgery, 5th ed. Saunders, 2004:1067-1076 2. Antinori A, Ammassari A, De Luca A, Cingolani A, Murri R, Scoppettuolo G, Fortini M, Tartaglione T, Larocca LM, Zannoni G, Cattani P, Grillo R, Roselli R, Jacoangeli M, Secrrati M, Ortona L:Diagnosis of AIDS-related focal brain lesions
  3. a decision making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 48(3): 687-694,1997 3. Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M, Guy G, Lapierre F: Primary intracerebral malignant lymphoma: Report of 248 cases. J Neurosurg 92(2):261-266, 2000 4. Batchelor T, Leoffler JS: Primary CNS lymphoma. J Clin Oncol 24(8):1281-1288, 2006 5. Benjamin WC, Marcus SM, Allan Topham, Hauck W, Walter J, Curran Jr: Will primary central nervous system lymphoma be the most frequent brain tumour diagnosed in the year 2000? Cancer 12:2409-2413,1997 6. Bhagavathi S, Wilson JD. Primary central nervous system lymphoma. Arch Pathol Lab Med 132(11):1830-1834,2009 7. Blay J-Y, Conroy T, Chevreau C, Thyss A, Quesnel N, Eghbali H:High-dose methotrexate for the treatment of primary cerebral lymphomas: An analysis of survival and late neurological toxicity in a retrospective series. J Clin Oncol 16:864-871,1998 8. Bleyer WA:Neurological sequelae of methotrexate and ionizing radiation: A new classification. Cancer Treat Rep 65:89-98,1981 9. Camilleri-Broet S, Martin A, Moreau A, Angomin R, Henin D, Gontier MF, Rousselet MC, Caulet Maugendre S, Cuilliere P, Lefrancq T, Mokhtari K, Morcos M, Broet P, Kujas M, Hauw JJ, Desablens B, Raphael M: Primary central nervous system lymphomas in 72 immunocompetent patients pathologic findings and clinical correlations. Groupe Ouest Est D’etude des Leucenies et Autres Maladies du Sang (GOELAMS). Am J Clin Pathol 110(5):607-612, 1998 10. Kadoch C, Tresseler P, Rubenstein JL: Molecular pathogenesis of primary central nervous system lymphoma. Neurosurgery Focus 21(5):1,2006 11. Cote TR, Manns A, Hardy CR, Yhartge PFJ: Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 88(10):675-679, 1996 12. Coulon A, Lafitte F, Loang-Xuan K, Martin-Duverneuil N, Mokhtari K, Blustajn J, Chiras J: Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur Radiol 12(2):329-340,2002 13. De Angelis L